oritavancin Injection [Orbactiv]

This article was written with the aim to establish a consensus clinical pathway for long-acting lipoglycopeptide antibiotics such… (More)

Oritavancin (Orbactiv®) is a new generation lipoglycopeptide approved for use in adult patients with acute bacterial skin and… (More)

Oritavancin (Orbactiv®) is a lipoglycopeptide antibacterial drug with activity against Gram-positive bacteria developed by The… (More)